| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Human immunodeficiency virus (HIV) | 11 | 2 | |
| General health | 1 | 0 | |
| Participate in clinical trial | 1 | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 2 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Human immunodeficiency virus (HIV) | 11 | 2 | |
| General health | 1 | 0 | |
| Participate in clinical trial | 1 | 1 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 2 |